Survenue de un ou plusieurs cas de gale. Conduite à tenir (HCSP ...

[101] Bachewar NP, Thawani VR, Mali SN, et al. Comparison of safety, efficacy, and costeffectiveness of benzyl benzoate, permethrin, and ivermectin in patients of scabies.Indian J Pharmacol 2009; 41: 9-14.[102] Bouvresse S, Chosidow O. « [Cutaneous ectoparasitosis] ». La Revue Du Praticien2011; 61(6): 867-73.[103] Lee B, Groth P. Scabies: transcutaneous poisoning during treatment Pediatrics 1977;59 : 643.[104] Fontan I, Taïeb A, Klene C, Maleville J. [Critical review of scabies treatments] ». AnnDermatol Vénéréol 1986; 113 : 593–96.[105] Mytton OT, McGready R, Lee SJ, et al. Safety of benzyl benzoate lotion and permethrinin pregnancy : a retrospective matched cohort study. Br J Obstet Gynecol 2007; 114:582-87.[106] Porto I. Anti parasitic drugs and lactation: focus on antihelmintics, scabicides, andpediculicides. J Hum Lact 2003; 19: 421-25.[107] Del Giudice P, Chosidow O, Caumes E. Ivermectin in dermatology. J Drugs Dermatol.2003; 2: 13-21.[108] Haas N, Lindermann U, Frank K, Sterry W, Lademann J, Katzung W. Rapid andpreferential sebum secretion of ivermectin : a new factor that may determine drugresponsiveness in patients with scabies. Arch Dermatol 2002; 138: 1618-19.[109] Macotela-Ruiz E, Pena Gonzalez G. Tratamiento des escabiosis humana conivermectina. Dermatologica Rev Mex 1996; 40: 179-84.[110] Chouela, EN, Abeldaño AM, Pellerano G, La Forgia M, Papale RM, Garsd A, DelCarmen Balian M, Battista V, Poggio N. Equivalent therapeutic efficacy and safety ofivermectin and lindane in the treatment of human scabies.Arch Dermatol 1999; 135: 651-55.[111] Madan V, Jaskiran K, Gupta U, Gupta DK. Oral ivermectin in scabies patients: acomparison with 1% topical lindane lotion. J Dermatol. 2001; 28: 4818-14.[112] Usha V, Golopalakrishnan TV. A comparative study of oral ivermectin and topicalpermethrin cream in the treatment of scabies. J Am Acad Dermatol 2000; 42: 236-40.[113] Goldust M, Rezaee E, Hemayat S. Treatment of scabies: Comparison of permethrin5% versus ivermectin. J Dermatol 2012; 39: 545-47.[114] Sharma R, Singal A. Topical permethrin and oral ivermectin in the management ofscabies: a prospective, randomized, double blind, controlled study. Indian J DermatolVenereol Leprol 2011 ; 77: 581-86.[115] Marty P, Gari-Toussaint M, Le Fichoux Y, Gaxotte P. Efficacy of ivermectin in thetreatment of an epidemic of sarcoptic scabies. Ann Trop Med Parasitol 1994; 88: 453.[116] Aubin F, Humbert P. Ivermectin for crusted (Norwegian) scabies. N Engl J Med 1995;332: 612.[117] Meinking TL, Taplin D, Hermida JL, Pardo R, Kerdel F. The treatment of scabies withivermectin. N Engl J Med 1995; 333: 26-30.[118] Del Giudice P, Carles M, Couppié P, et al. Successful treatment of crusted (Norwegian)scabies with ivermectin in two patients with human immunodeficiency virus infection. Br JDermatol 1996; 135: 494-95.[119] Alberici F, Pagani L, Ratti G, Viale P. Ivermectin alone or in combination with benzylbenzoate in the treatment of human immonodeficiency virus-associated scabies. Br JDermatol 2000; 142: 969-72.Recommandations relatives à la conduite à tenir devant un ou plusieurs cas de gale/Novembre 2012 55